DR5, recombinant, humaan (Apo2, trail-R2, TRAIL Receptor2, trail Receptor-2)

9000-83-3

8795

Lyophilized powder may be stored at -20 °C. Stable for 12 months at -20 °C. Reconstitute with sterile dH2O. Aliquot to avoid repeated freezing and thawing. Store at -20 °C. Reconstituted product is stable for 6 months at -20 °C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

[TNFRSF10B; TNFRSF10B; DR5; CD262; KILLER; TRICK2; TRICKB; ZTNFR9; TRAILR2; TRICK2A; TRICK2B; TRAIL-R2; KILLER/DR5; DR5; KILLER; TRAILR2; TRICK2; ZTNFR9; TRAIL receptor 2; TRAIL-R2]

[DR5]

[DR5; Tumor necrosis factor receptor superfamily member 10B; tumor necrosis factor receptor superfamily member 10B; Fas-like protein; death receptor 5; cytotoxic TRAIL receptor-2; apoptosis inducing receptor TRAIL-R2; apoptosis inducing protein TRICK2A/2B; TNF-related apoptosis-inducing ligand receptor 2; death domain containing receptor for TRAIL/Apo-2L; tumor necrosis factor receptor-like protein ZTNFR9; p53-regulated DNA damage-inducible cell death receptor(killer); tumor necrosis factor receptor superfamily, member 10b; Death receptor 5; TNF-related apoptosis-inducing ligand receptor 2]

3721878

BAA33723.1

O14763